Literature DB >> 9699864

N-terminal sequences of the human androgen receptor in DNA binding and transrepressing functions.

A Gast1, J Schneikert, A C Cato.   

Abstract

Androgen receptor is a ligand binding transcription factor that controls several physiological processes ranging from the development of the male sexual organs to the acquisition of secondary sex characteristics. It is composed of a carboxy-terminal ligand binding domain, a centrally located DNA binding domain and an amino terminal modulator region. Detailed study on the DNA and carboxy-terminal regions have been carried out, but only limited information is available on the activity of the N-terminus. With the use of truncated and chimeric receptor constructs we have demonstrated in transient transfection experiments that the N-terminus of the androgen receptor contributes to DNA binding, transactivation and transrepression functions of the receptor. We have shown that specific sequences at the N-terminus are needed for transactivation but we were unable to identify discrete sequences in this region for the DNA binding and transrepression functions. Sequences from the transcription factor NFI/X3 that bear no homology to the N-terminus of the androgen receptor nevertheless functionally replaced it in enhancing DNA binding, transrepression but not transactivation functions of the receptor. Thus, it appears that the structure rather than sequence specific elements determines the contribution of the N-terminus of the androgen receptor to DNA binding and transrepression functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699864     DOI: 10.1016/s0960-0760(97)00176-3

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  3 in total

1.  The cochaperone Bag-1L enhances androgen receptor action via interaction with the NH2-terminal region of the receptor.

Authors:  Liubov Shatkina; Sigrun Mink; Hermann Rogatsch; Helmut Klocker; Gernot Langer; Andrea Nestl; Andrew C B Cato
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

2.  Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer.

Authors:  Barbara Comuzzi; Marianne D Sadar
Journal:  Cellscience       Date:  2006-07-27

3.  NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.

Authors:  Maria Papaioannou; Sonja Schleich; Daniela Roell; Undine Schubert; Tamzin Tanner; Frank Claessens; Rudolf Matusch; Aria Baniahmad
Journal:  Invest New Drugs       Date:  2009-09-23       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.